Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth

Japanese Journal of Cancer Research

Volumn 90, Issue 2, 1999, Pages 194-204

  Oji, Yusuke ^a   Ogawa, Hiroyasu ^b   Tamaki, Hiroya ^b   Oka, Yoshihiro ^b   Tsuboi, Akihiro ^b   Kim, Eui Ho ^b   Soma, Toshihiro ^b   Tatekawa, Toyoshi ^b   Kawakami, Manabu ^b   Asada, Momotaro ^a   Kishimoto, Tadamitsu ^c   Sugiyama, Haruo ^a  

^a Dept of Clinical Laboratory Science ^*  (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Solid tumors; Tumor suppressor gene; Wilms' tumor gene; WT1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG CANCER; NEPHROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLID TUMOR; STOMACH CANCER; THYROID CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UTERUS CANCER;

EID: 0032992295     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00733.x     Document Type: Article

References (54)

1. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., Jones, C. and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60, 509-520 (1990).
2. Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H. and Bruns, G. A. P. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-778 (1990).
3. Gashler, A. L., Bonthron, D. T., Madden, S. L., Rauscher, F. J., III, Collins, T. and Sukhatme, V. P. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl. Acad. Sci. USA, 89, 10984-10988 (1992).
4. Harrington, M. A., Konicek, B., Song, A., Xia, X.-L., Fredericks, W. J. and Rauscher, F. J., III Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem., 268, 21271-21275 (1993).
5. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P. and Rauscher, F. J., III Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science, 257, 674-678 (1992).
6. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., Rauscher, F. J., III, Sens, D. A., Garvin, A. J., LeRoith, D. and Roberts, C. T., Jr. Increased expression of the insulin-like growth factor I receptor gene, IGFIR, in Wilms tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. USA, 90, 5828-5832 (1993).
7. Godyer, P., Dehbi, M., Torban, E., Bruening, W. and Pelletier, J. Repression of the retinoic acid receptor-α gene by the Wilms tumor suppressor gene product, wtl. Oncogene, 10, 1125-1129 (1995).
8. Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J., III and Saunders, G. F. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res., 55, 5386-5389 (1995).
9. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T. and Kishimoto, T. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079 (1994).
10. Tamaki, H., Ogawa, H., Inoue, K., Soma, T., Yamagami, T., Miyake, S., Oka, Y., Oji, Y., Tatekawa, T., Tsuboi, A., Tagawa, S., Kitani, T., Miwa, H., Kita, K., Aozasa, K., Kishimoto, T. and Sugiyama, H. Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia. Blood, 88, 4396-4399 (1996).
11. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., Maekawa, T. and Kishimoto, T. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukeniogenesis. Blood, 87, 2878-2884 (1996).
12. Inoue, K., Tamaki, H., Ogawa, H., Oka, Y., Soma, T., Tatekawa, T., Oji, Y., Tsuboi, A., Kim, E. H., Kawakami, M., Akiyama, T., Kishimoto, T. and Sugiyama, H. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood, 91, 2969-2976 (1998).
13. Bruening, W., Gros, P., Sato, T., Stanimir, J., Nakamura, Y., Housman, D. and Pelletier, J. Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors. Cancer Invest., 11, 393-399 (1993).
14. Coppes, M. J., Ye, Y., Rackley, R., Zhao, X.-L., Liefers, G. J., Casey, G. and Williams, B. R. G. Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. Cancer Res., 53, 2712-2714 (1993).
15. Park, S., Schalling, M., Bernard, A., Maheswaran, S., Shipley, G. C., Roberts, D., Fletcher, J., Shipman, R., Rheinwald, J., Demetri, G., Griffin, J., Minden, M., Housman, D. E. and Haber, D. A. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat. Genet., 4, 415-420 (1993).
16. Amin, K. M., Litzky, L. A., Smythe, W. R., Mooney, A. M., Morris, J. M., Mews, D. J. Y., Pass, H. I,.. Kari, C., Rodeck, U., Rauscher, F. J., III, Kaiser, L. R. and Albelda, S. M. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant methothelioma. Am. J. Pathol., 146, 344-356 (1995).
17. Silberstein, G. B., Van Horn, K., Strickland, P., Roberts, C. T., Jr. and Daniel, C. W. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proc. Natl. Acad. Sci. USA, 94, 8132-8137 (1997).
18. Haber, D. A., Park, S., Maheswaran, S., Englert, C., Re, G. G., Hazen-Martin, D. J., Sens, D. A. and Garvin, A. J. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science, 262, 2057-2059 (1993).
19. Luo, X.-N., Reddy, J. C., Yeyati, P. L., Idris, A. H., Hosono, S., Haber, D. A., Licht, J. D. and Atweh, G. F. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene, 11, 743-750 (1995).
20. Menke, A. L., Riteco, N., Van Ham, R. C. A., De Bruyne, C., Rauscher, F. J., III, Van der Eb, A. J. and Jochemsen, A. G. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene, 12, 537-546 (1996).
21. Maheswaran, S., Park, S., Bernard, A., Morris, J. F., Rauscher, F. J., III, Hill, D. E. and Haber, D. A. Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA, 90, 5100-5104 (1993).
22. Johnstone, R. W., See, R. H., Sells, S. F., Wang, J., Muthukkumar, S., Englert, C., Haber, D. A., Licht, J. D., Sugrue, S. P., Roberts, T., Rangnekar, V. M. and Shi, Y. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol. Cell. Biol., 16, 6945-6956 (1996).
23. Sekiya, M., Adachi, M., Hinoda, Y., Imai, K. and Yachi, A. Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood, 83, 1876-1882 (1994).
24. Phelan, S. A., Lindberg, C. and Call, K. M. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Diff., 5, 677-686 (1994).
25. Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T. and Sugiyama, H. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood, 89, 1405-1412 (1997).
26. + hematopoietic progenitors during development and early clonogenic growth. Blood, 89, 3486-3493 (1997).
27. Baird, P. N. and Simmons, P. J. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. Exp. Hematol., 25, 312-320 (1997).
28. + progenitors and downregulated early in the course of differentiation in vitro. Exp. Hematol., 25, 945-950 (1997).
29. Kamei, H. Nuclear granules recognized by some monoclonal antibody against intermediate filament protein locate on chromosomes during mitosis. Cell Biol. Int. Rep., 13, 291-299 (1989).
30. Hojo, H. Establishment of cultured cell line of human stomach cancer origin and their morphological characteristics. Niigata Med. J., 91, 737-752 (1977).
31. Motoyama, T., Hojo, H. and Watanabe, H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. Jpn., 36, 65-83 (1986).
32. Nozue, M., Nishida, M., Todoroki, T. and Iwasaki, Y. Establishment and characterization of a human scirrhous type gastric cancer cell line, GCIY, producing CA19-9. Hum. Cell, 4, 71-75 (1991).
33. Leibovitz, A., Stinson, J. C., McCombs, W. B., III, McCoy, C. E., Mazur, K. C. and Mabry, N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36, 4562-4569 (1976).
34. Quinn, L. A., Moore, G. E., Morgan, R. T. and Woods, L. K. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res., 39, 4914-4924 (1979).
35. Drewinko, B., Romsdahl, M. M., Yang, L. Y., Ahearn, M. J. and Trujillo, J. M. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res., 36, 467-475 (1976).
36. von Kleist, S., Chany, E., Burtin, P., King, M. and Fogh, J. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J. Natl. Cancer Inst., 55, 555-560 (1975).
37. Miyazaki, K., Takaku, H., Umeda, M., Fujita, T., Huang, W., Kimura, T., Yamashita, J. and Horio, T. Potent growth inhibition of human tumor cells in culture by arginine deaminase purified from a culture medium of a mycoplasma-infected cell line. Cancer Res., 50, 4522-4527 (1990).
38. Tanio, Y., Watanabe, M., Inoue, T., Kawase, I., Shirasaka, T., Ikeda, T., Hara, H., Masuno, T., Saito, S., Kawano, K., Kitamura, H., Kubota, K., Kodama, N., Kawahara, M., Sakatani, M., Furuse, K., Yamamoto, S. and Kishimoto, S. Chemo-radioresistance of small cell lung cancer cell lines derived from untreated primary tumors obtained by diagnostic bronchofiberscopy. Jpn. J. Cancer Res., 81, 289-297 (1990).
39. Kyoizumi, S., Akiyama, M., Kouno, N., Kobuke, K., Hakoda, M., Jones, S. L. and Yamakido, M. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. Cancer Res., 45, 3274-3281 (1985).
40. Sakuma, T., Kodama, K., Hara, T., Eshita, Y., Shibata, N., Matsumoto, M., Seya, T. and Mori, Y. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma. Jpn. J. Cancer Res., 84, 753-759 (1993).
41. Mogi, H., Hasegawa, Y., Watanabe, A., Nomura, F., Saka, H. and Shimokata, K. Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro. Cancer Chemother. Pharmacol., 39, 199-204 (1997).
42. Suzuki, K., Ota, H., Hirohashi, S., Taya, Y., Shimosato, Y., Kuramoto, A. and Fujikura, T. Chemotactic factor for polymorphonuclear leukocytes derived from human lung giant cell carcinoma Lu65 cells. J. Clin. Biochem. Nutr., 6, 147-153 (1989).
43. Itoh, H., Kataoka, H., Koita, H., Nabeshima, K., Inoue, T., Kangawa, K. and Koono, M. Establishment of a new human cancer cell line secreting protease nexin-II/amyloid beta protein precursor derived from squamous-cell carcinoma of lung. Int. J. Cancer, 49, 436-443 (1991).
44. Kataoka, H., Itoh, H., Seguchi, K. and Koono, M. Establishment and characterization of a human lung adenocarcinoma cell line (LC-2/ad) producing alpha 1-antitrypsin in vitro. Acta Pathol. Jpn., 43, 566-573 (1993).
45. Lee, Y.-C., Saijo, N., Sasaki, Y., Takahashi, H., Sakurai, M., Ishihara, J., Hoshi, A., Chen, K.-M. and Hamburger, A. W. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay. Jpn. J. Clin. Oncol., 15, 637-644 (1985).
46. Yamane, M., Nishiki, M., Kataoka, T., Kishi, N., Amano, K., Nakagawa, K., Okumichi, T., Naito, M., Ito, A. and Ezaki, H. Establishment and characterization of new cell line (YMB-1) derived from human breast carcinoma. Hiroshima J. Med. Sci., 33, 715-720 (1984).
47. Cailleau, R., Young, R., Olivé, M. and Reeves, W. L., Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst., 53, 661-674 (1974).
48. Keydar, I., Chen, L., Karbey, S., Weiss, F. R., Declarca, J., Radu, M., Chaitcik, S. and Brenner, M. J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer, 15, 659-670 (1979).
49. Engel, L. W., Young, N. A., Tralka, T. S., Lippman, M. E., O'Brien, S. J. and Joyce, M. J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res., 38, 3352-3364 (1978).
50. Motoyama, T., Watanabe, H., Yamamoto, T. and Sekiguchi, M. Human testicular germ cell tumors in vitro and in athymic nude mice. Acta Pathol. Jpn., 37, 431-448 (1987).
51. Yoshiya, N. Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs. Acta Obstet. Gynaecol. Jpn., 38, 1747-1753 (1986).
52. Scherer, W. F. and Hoogasian, A. C. Preservation at subzero temperatures of mouse fibroblasts (Strain L) and human epithelial cells (Strain HeLa). Proc. Soc. Exp. Biol. Med., 87, 480-487 (1954).
53. Ito, T., Seyama, T., Hayashi, T., Dohi, K., Mizuno, T., Iwamoto, K., Tsuyama, N., Nakamura, N. and Akiyama, M. Establishment of two human thyroid carcinoma cell lines (8305C, 8505C) bearing p53 gene mutations. Int. J. Oncol., 4, 583-586 (1994).
54. Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I. and Knowles, B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615-616 (1979).